Patent ID: 11918693
Assignee: HALEON US HOLDINGS LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 1:
2. The oral tablet according to claim 1 comprising:
(i) the active ingredients present intragranularly;
(ii) 5% to 20% by weight pregelatinized starch present intragranularly;
(iii) 0.5% to 2.5% by weight Hypromellose present intragranularly;
(iv) 0.5% to 3% by weight of glyceryl dibehenate present extragranularly;
(v) 1% to 10% by weight croscarmellose present intragranularly and extragranularly; and
(vi) 1% to 5% by weight colloidal silicon dioxide present intragranularly and extragranularly.